-
Signature
-
/s/ Brian Grube, Attorney-in-Fact
-
Issuer symbol
-
INTA
-
Transactions as of
-
01 Jun 2023
-
Net transactions value
-
-$78,606
-
Form type
-
4
-
Filing time
-
02 Jun 2023, 16:34:56 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
INTA |
Common Stock |
Award |
$2,396 |
+124 |
+0.6% |
$19.32 |
20,815 |
31 May 2023 |
Direct |
F1 |
| transaction |
INTA |
Common Stock |
Options Exercise |
$85,080 |
+4,000 |
+19% |
$21.27 |
24,815 |
01 Jun 2023 |
Direct |
F2 |
| transaction |
INTA |
Common Stock |
Sale |
$36,785 |
-900 |
-3.6% |
$40.87 |
23,915 |
01 Jun 2023 |
Direct |
F2, F3, F4 |
| transaction |
INTA |
Common Stock |
Sale |
$74,407 |
-1,800 |
-7.5% |
$41.34 |
22,115 |
01 Jun 2023 |
Direct |
F2, F3, F4 |
| transaction |
INTA |
Common Stock |
Sale |
$54,890 |
-1,300 |
-5.9% |
$42.22 |
20,815 |
01 Jun 2023 |
Direct |
F2, F3, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
INTA |
Employee Stock Option (right to buy) |
Options Exercise |
$0 |
-4,000 |
-3.7% |
$0.000000 |
104,000 |
01 Jun 2023 |
Common Stock |
4,000 |
$21.27 |
Direct |
F2, F5 |
| holding |
INTA |
Employee Stock Option (right to buy) |
|
|
|
|
|
20,000 |
01 Jun 2023 |
Common Stock |
|
$21.27 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: